article thumbnail

Envision acquires commercial solutions firm Two Labs

pharmaphorum

Scientific communications company Envision Pharma has bought Two Labs, a firm specialising in commercial solutions for the pharma and biotech sector, for an undisclosed sum. The acquisition followed an investment in Envision by specialist European fund Global Healthcare Opportunities (GHO) earlier this month.

article thumbnail

To List or Not to List; That is the Question – The FTC Signals the Potential for Greater Scrutiny of Patent Information Submissions to FDA

The FDA Law Blog

The closest FDA has come is in a 2003 preamble noting that patents that claim finished dosage forms—which can include “metered aerosols, capsules, metered sprays, gels, and pre-filled drug delivery systems”—should be listed in the Orange Book, suggesting that a patent that claims both the drug substance and the delivery device should be listed.

FDA 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Naltrexone interactions to avoid

The Checkup by Singlecare

Communicating openly with your healthcare team about all medical conditions you have and medications you take is the best way to identify potential naltrexone interactions. Keeping open communication with your healthcare provider ensures proper management and monitoring of your health.

article thumbnail

Paediatric oral compounding: expert insights from a global study

Hospital Pharmacy Europe

Furthermore, it is imperative to raise physician awareness of the practice of compounding and ensure communication between physicians and pharmacists to achieve accurate paediatric prescribing. Concerns were also raised about formulations that use excipients with safety issues, such as ethanol, propylene glycol and parabens.

article thumbnail

Jim White, MD

Blog: Ask a Student Pharmacist

Dr. White values the importance of communication between providers and patients in relation to quality care. Outstanding patient care requires great communication. 2003 Nov 11;61(9):1218-21. White JR, Walczak TS, Leppik IE, Rarick J, Tran T, Beniak TE, Matchinsky DJ, Gumnit RJ. doi: 10.1212/01.wnl.0000091865.46063.67.

article thumbnail

Theranos founder Elizabeth Holmes guilty of fraud, says jury

pharmaphorum

They also used direct communication, marketing materials, media and financial statements, models and other information to defraud potential investors, according to the complaint. Theranos raised almost $1 billion from investors before the company and its claims were eventually exposed as a sham.

article thumbnail

The 20 Key Moments in the 340B Program's 30-Year History

Omnicell

2003: Congress passed the Medicare Modernization Act (MMA), which included the creation of the Medicare Part D program. The investigation, which included inquiries requesting large amounts of documents and communications from various stakeholders, is largely perceived as a drug industry-friendly fact-finding exercise.